🇺🇸 Therapeutic plasma exchange in United States

12 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 12

Most-reported reactions

1. Bacteraemia — 2 reports (16.67%)
2. Drug Effective For Unapproved Indication — 2 reports (16.67%)
3. Off Label Use — 2 reports (16.67%)
4. Drug Ineffective — 1 report (8.33%)
5. Drug Interaction — 1 report (8.33%)
6. Haemodynamic Instability — 1 report (8.33%)
7. Hypocalcaemia — 1 report (8.33%)
8. Hypotension — 1 report (8.33%)
9. Hypoxia — 1 report (8.33%)

Source database →

Frequently asked questions

Is Therapeutic plasma exchange approved in United States?

Therapeutic plasma exchange does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Therapeutic plasma exchange in United States?

Centre Hospitalier St Anne is the originator. The local marketing authorisation holder may differ — check the official source linked above.